New pharmacologic approaches in the management of osteoarthritis


  • Thomas J. Schnitzer

    Corresponding author
    1. Feinberg School of Medicine, Northwestern University, Chicago, Illinois
    • 710 North Lake Shore Drive, Room 1020, Chicago, IL 60611
    Search for more papers by this author
    • Dr. Schnitzer has received consultant fees, speaking fees, and/or honoraria (less than $10,000 each) from Logical Therapeutics, Stryker Biotech, Eli Lilly, Winston Laboratories, Merck & Co., and Covidien, and (more than $10,000) from NicOx SA, and owns stock and/or holds stock options in NicOx SA.